Endra Life SciencesNDRA
13F holders, Q2 2026 (June 30)10holders +2
3new positions
1sold out
1famous investor
$5.33avg. 13F price*
At the end of Q2 2026, 10 institutions reported holding Endra Life Sciences Inc. (NDRA) in their 13F filings, up 2 from Q1 2026. 3 opened new positions and 1 sold out. The largest holders were Altium Capital Management LLC ($316K), Citadel Advisors ($159K) and Citizens Financial Group Inc. ($151K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Endra Life Sciences Inc.
- CUSIP
- 29273B500
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $311K |
| Exits | 1 | $19 |
All 13F filers, Q1 2026 → Q2 2026: 70,277 shares bought and 6,256 shares sold, net +64,021 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Altium Capital Management LLC | 0.67% | Add +14.2% | 59,272 | $316K |
| Citadel Advisors | 0.00% | New | 29,924 | $159K |
| Citizens Financial Group Inc. | 0.00% | New | 28,400 | $151K |
| Geode Capital Management, LLC | 0.00% | Reduce -29.3% | 14,910 | $79K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 10,121 | $54K |
| Vanguard Capital Management LLC | 0.00% | Add +160.6% | 7,339 | $39K |
| Morgan Stanley | 0.00% | No change | 3,546 | $19K |
| UBS Group AG | 0.00% | Reduce -55.3% | 68 | $362 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 58 | $309 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 19 | $101 |
"% of holder's portfolio" is NDRA's weight in each manager's 13F, not the share of Endra Life Sciences Inc. the manager owns.